Cargando…
Attainment of therapeutic vancomycin level within the first 24 h: Authors' response
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852771/ https://www.ncbi.nlm.nih.gov/pubmed/31722733 http://dx.doi.org/10.1186/s13054-019-2639-7 |
| _version_ | 1783469910985277440 |
|---|---|
| author | Baptista, João Pedro Roberts, Jason A. Sousa, Eduardo Freitas, Ricardo Devesa, Nuno Pimentel, Jorge |
| author_facet | Baptista, João Pedro Roberts, Jason A. Sousa, Eduardo Freitas, Ricardo Devesa, Nuno Pimentel, Jorge |
| author_sort | Baptista, João Pedro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6852771 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68527712019-11-20 Attainment of therapeutic vancomycin level within the first 24 h: Authors' response Baptista, João Pedro Roberts, Jason A. Sousa, Eduardo Freitas, Ricardo Devesa, Nuno Pimentel, Jorge Crit Care Letter BioMed Central 2019-11-13 /pmc/articles/PMC6852771/ /pubmed/31722733 http://dx.doi.org/10.1186/s13054-019-2639-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Letter Baptista, João Pedro Roberts, Jason A. Sousa, Eduardo Freitas, Ricardo Devesa, Nuno Pimentel, Jorge Attainment of therapeutic vancomycin level within the first 24 h: Authors' response |
| title | Attainment of therapeutic vancomycin level within the first 24 h: Authors' response |
| title_full | Attainment of therapeutic vancomycin level within the first 24 h: Authors' response |
| title_fullStr | Attainment of therapeutic vancomycin level within the first 24 h: Authors' response |
| title_full_unstemmed | Attainment of therapeutic vancomycin level within the first 24 h: Authors' response |
| title_short | Attainment of therapeutic vancomycin level within the first 24 h: Authors' response |
| title_sort | attainment of therapeutic vancomycin level within the first 24 h: authors' response |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6852771/ https://www.ncbi.nlm.nih.gov/pubmed/31722733 http://dx.doi.org/10.1186/s13054-019-2639-7 |
| work_keys_str_mv | AT baptistajoaopedro attainmentoftherapeuticvancomycinlevelwithinthefirst24hauthorsresponse AT robertsjasona attainmentoftherapeuticvancomycinlevelwithinthefirst24hauthorsresponse AT sousaeduardo attainmentoftherapeuticvancomycinlevelwithinthefirst24hauthorsresponse AT freitasricardo attainmentoftherapeuticvancomycinlevelwithinthefirst24hauthorsresponse AT devesanuno attainmentoftherapeuticvancomycinlevelwithinthefirst24hauthorsresponse AT pimenteljorge attainmentoftherapeuticvancomycinlevelwithinthefirst24hauthorsresponse |